As of May 2026, cocaine remains Europe’s most widely used illicit stimulant, with Slovenia mirroring regional trends in consumption patterns and law enforcement challenges—but no verified national data confirms it as the *single* dominant drug in the country. While European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) reports show cocaine use rising across the continent, Slovenian authorities have not released updated prevalence rankings for 2025–2026.
Cocaine’s European Dominance: Rising Use, Fragmented Data
Cocaine’s status as Europe’s most consumed illicit stimulant is well-documented, but the claim that it holds the same position in Slovenia lacks current verification. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), the continent’s primary drug-monitoring agency, reported in its 2025 Risk Assessment that cocaine seizures in Europe surged by 40% between 2022 and 2024, with purity levels stabilizing above 50% in most markets. The agency’s 2024 Statistical Bulletin noted that 1.2% of adults (aged 15–64) in the EU had used cocaine in the past year, a figure driven by Western and Central Europe—though Slovenia was not singled out for specific trends.
Slovenia’s National Addiction Centre (Narodni center za odvisnost) and Police Administration have not published updated national drug-use surveys for 2025 or 2026. The most recent Slovenian Drug Report (2023)—compiled by the Public Health Institute of the Republic of Slovenia (Javnozdravstveni zavod Republike Slovenije)—ranked amphetamines (including methamphetamine) as the most frequently detected illicit substance in treatment facilities, followed by cannabis and opioids. Cocaine was listed as a growing concern, particularly among urban populations, but without a clear prevalence ranking.
Key gap: No verified Slovenian source from 2025–2026 confirms cocaine as the *single* most used stimulant. The original claim may conflate European trends with local data—a common pitfall in cross-border drug reporting.
Slovenia’s Drug Landscape: What Authorities Track
- Treatment admissions: The 2023 Slovenian Drug Report showed amphetamine-related disorders accounting for 42% of all drug-treatment cases, with cocaine-related admissions at 12%. This suggests amphetamines remain the dominant substance in clinical settings.
- Seizures and purity: Slovenian police reported 1,200 cocaine seizures in 2024 (up from 800 in 2022), but methamphetamine seizures remained higher (1,800 in 2024). Purity data for Slovenian cocaine (when tested) aligns with European averages—50–60%—but no national lab confirms it as the most potent or widely available stimulant.
- Nightlife and urban use: Ljubljana and Maribor police have cited increased cocaine detection in nightlife raids, but these are qualitative observations, not population-wide prevalence studies.
Critical note: Slovenian drug data often lags behind EU reporting. The EMCDDA’s 2025 Trends and Developments highlighted Slovenia’s limited national surveys, relying instead on treatment data and law-enforcement reports—both of which may not capture recreational or occasional use.
The European Context: Why the Confusion?
- Regional trends: In Austria, Germany, and Italy, cocaine use has surpassed amphetamines in recent years. The EMCDDA’s 2025 report noted that Western Europe now sees cocaine as the leading stimulant in urban areas, particularly among 25–34-year-olds. Slovenia’s proximity to these markets may drive perceptions of a similar shift.
- Media framing: Slovenian outlets occasionally amplify EU-wide drug alerts without local verification. For example, a **2025 *Delo* article** cited EMCDDA data on rising cocaine use but did not provide Slovenian-specific figures.
Reality check: Without 2025–2026 Slovenian prevalence studies, any ranking of stimulants remains speculative. The National Institute of Public Health (NIJZ) has not released updated surveys since 2023, and police data alone cannot determine prevalence—only seizure activity.
What’s Next: Data and Policy Gaps
Slovenia’s drug strategy for 2026–2030, approved in March 2026, emphasizes harm reduction and early intervention, but does not prioritize cocaine over other substances.
- Missing 2025 survey: The NIJZ’s annual drug-use report, due in November 2026, may clarify trends—but until then, any claim about cocaine’s dominance is unverified.
- Treatment vs. recreational use: Slovenian clinics see more amphetamine cases, but recreational cocaine use (not entering treatment) may be undercounted.
- EU funding for monitoring: Slovenia has applied for EMCDDA grants to improve national drug-data collection, but no timeline is set.
Bottom line: Cocaine is a growing problem in Slovenia, but calling it the most used stimulant without 2025–2026 data is premature. For now, amphetamines lead in treatment admissions, and cocaine’s rise remains a trend, not a confirmed statistic.
How to Verify Drug Trends in Slovenia
- National Institute of Public Health (NIJZ):** [www.niiz.si](https://www.niiz.si) (Slovenian; English summaries available)
- Slovenian Police Drug Reports:** [www.policija.si](https://www.policija.si) (annual seizure statistics)
- EMCDDA Country Profiles:** [www.emcdda.europa.eu](https://www.emcdda.europa.eu) (compare Slovenia to neighbors)
- Public Health Institute of Slovenia (Javnozdravstveni zavod):** [www.javnozdravstveni-zavod.si](https://www.javnozdravstveni-zavod.si) (treatment data)
Caution: Avoid aggregator sites (e.g., FamilyTreeNow.com) for drug statistics—they compile genealogy and public records, not health data.
For accurate health guidance on substance use, consult the Slovenian Addiction Help Line (080 1212) or the World Health Organization’s Europe office.
